With effect from October 11, 2023, the unit rights in Amniotics AB will be traded on First North Growth Market. Trading will continue up until and including October 20, 2023. Instrument: Unit rights Short name: AMNI UR Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0020848414 Order book ID: 307619 Market Segment: First North STO Tick Size: MiFID II tick size table With effect from October 11, 2023, the paid subscription units in Amniotics AB will be traded on First North Growth Market. Trading will continue until further notice. Instrument: Paid subscription units Short name: AMNI BTU Clearing: Bilateral settlement at Euroclear Sweden ISIN code: SE0020848422 Order book ID: 307618 Market Segment: First North STO Tick Size: MiFID II tick size table For further information concerning this exchange notice please contact Issuer Surveillance, telephone +46 8 405 70 50, or iss@nasdaq.com Nasdaq Stockholm AB
Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Amniotics AB (522/23)
© 2023 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.03. | Nasdaq Stockholm AB: Amniotics AB (publ) receives observation status | On March 21, 2024, Amniotics AB (publ) (the "Company") disclosed a press
release with information on the Company's financial situation.
Today, on March 22, 2024, Magle Chemoswed Holding AB disclosed... ► Artikel lesen | |
| 22.11.23 | Nasdaq Stockholm AB: New equity right for trading, Amniotics AB TO3 (597/23) | At the request of Amniotics AB, Amniotics equity rights will be traded on First
North Growth Market as from November 24, 2023.
Security name: Amniotics option rights TO 3
--------------------------------------------
Short... ► Artikel lesen | |
| 10.10.23 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Amniotics AB (522/23) | With effect from October 11, 2023, the unit rights in Amniotics AB will be
traded on First North Growth Market. Trading will continue up until and
including October 20, 2023.
Instrument: Unit... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
